Interstitial Lung Disease (ILD)
Respiratory·MeSH: Lung Diseases, Interstitial
Prevalence
30.0 / 100K
1 drug in development·1 company·6 clinical trials
Drug Pipeline by Phase
Phase 2(1)
Frequently asked questions
How many drugs are in development for Interstitial Lung Disease (ILD)?
BioSniper tracks 1 drug in development for Interstitial Lung Disease (ILD) across 1 company.
How many clinical trials target Interstitial Lung Disease (ILD)?
There are 6 clinical trials targeting Interstitial Lung Disease (ILD) tracked by BioSniper.
What is the prevalence of Interstitial Lung Disease (ILD)?
The estimated prevalence of Interstitial Lung Disease (ILD) is approximately 30.0 per 100,000 population.
Deep-dive into Interstitial Lung Disease (ILD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis